SAREPTA THERAP (AB3A.SG)
SAREPTA THERAP (AB3A.SG) operates in Diversified Metals & Mining.
SAREPTA THERAP (AB3A.SG) (AB3A) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -0.058x
Based on the latest financial reports, SAREPTA THERAP (AB3A.SG) (AB3A) has a cash flow conversion efficiency ratio of -0.058x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-70.70 Million) by net assets (€1.22 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SAREPTA THERAP (AB3A.SG) - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how SAREPTA THERAP (AB3A.SG)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
SAREPTA THERAP (AB3A.SG) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SAREPTA THERAP (AB3A.SG) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Graphisoft Park SE
BUD:GSP
|
N/A |
|
Nur Ink Innovations Ltd
TA:NURI
|
-0.351x |
|
CEVA (PVJA.SG)
STU:PVJA
|
0.002x |
|
PIMCO DYNAMIC INCOME FD
F:1KF
|
N/A |
|
Amaya Big Sky Capital Corp.
V:AMYA-P
|
N/A |
|
Maj Invest - Maj Invest Vækstaktier KL
CO:MAJVA
|
N/A |
|
Haansoft
KO:030520
|
0.001x |
|
Nature's Miracle Holding Inc. Common Stock
NASDAQ:NMHI
|
0.121x |
Annual Cash Flow Conversion Efficiency for SAREPTA THERAP (AB3A.SG) (2016–2023)
The table below shows the annual cash flow conversion efficiency of SAREPTA THERAP (AB3A.SG) from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €859.34 Million | €-500.99 Million | -0.583x | +31.02% |
| 2022-12-31 | €384.95 Million | €-325.35 Million | -0.845x | -76.98% |
| 2021-12-31 | €928.01 Million | €-443.17 Million | -0.478x | -438.51% |
| 2020-12-31 | €761.76 Million | €107.47 Million | 0.141x | +125.29% |
| 2019-12-31 | €818.19 Million | €-456.46 Million | -0.558x | -48.18% |
| 2018-12-31 | €1.03 Billion | €-388.66 Million | -0.377x | -28.08% |
| 2017-12-31 | €789.22 Million | €-232.00 Million | -0.294x | +59.74% |
| 2016-12-31 | €336.69 Million | €-245.82 Million | -0.730x | -- |